Related Experiment Videos
Summary
Radiation therapy effectively treated bulky seminoma in 18 patients between 1969 and 1980. This approach resulted in a 94% disease-free survival rate with no treatment-related harm.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Physics
Background:
- Seminoma is a germ cell tumor that can occur in the retroperitoneum or mediastinum.
- Bulky disease presents a treatment challenge, often requiring multimodal approaches.
Purpose of the Study:
- To evaluate the efficacy and safety of radiation therapy for bulky retroperitoneal and mediastinal seminoma.
- To assess long-term disease-free survival and treatment-related morbidity in patients treated with radiation therapy.
Main Methods:
- Retrospective analysis of 18 patients with bulky seminoma (17 retroperitoneal, 1 mediastinal) treated between 1969 and 1980.
- Patients received radiation therapy, with some undergoing surgery or adjuvant chemotherapy.
- Adjuvant irradiation was administered to the mediastinum and paraclavicular lymph nodes in 15 patients.
Main Results:
- 17 out of 18 patients (94%) achieved disease-free survival at last follow-up.
- No treatment-related morbidity or mortality was observed in any patient.
- The study included patients with bulky retroperitoneal and mediastinal seminoma.
Conclusions:
- Radiation therapy is a highly effective and safe treatment modality for bulky retroperitoneal and mediastinal seminoma.
- Adjuvant irradiation to the mediastinum and paraclavicular lymph nodes may contribute to favorable outcomes.
- Long-term follow-up demonstrates durable disease control with minimal toxicity.